Ketoconazole Dosing for Hypercortisolism
For patients with hypercortisolism, the initial dose of ketoconazole should be 400-600 mg per day divided into 2-3 doses, which can be increased to 800-1,200 mg per day until cortisol levels normalize, followed by a maintenance dose of 400-800 mg per day in 2-3 divided doses. 1
Initial Dosing and Titration
- For patients over 12 years of age, ketoconazole should be initiated at 400-600 mg per day divided into 2-3 doses 1
- Dose can be increased to 800-1,200 mg per day until cortisol levels normalize 1, 2
- Once cortisol levels are controlled, the dose should be reduced to a maintenance level of 400-800 mg per day in 2-3 divided doses 1
- Normalization of urinary free cortisol (UFC) typically occurs within days to weeks of starting treatment 3, 4
Monitoring and Dose Adjustment
- Liver function tests should be monitored weekly during the first month of treatment due to risk of hepatotoxicity 5
- Cortisol levels should be regularly assessed to guide dose adjustments 2
- Approximately 15-23% of initially responsive patients may experience "escape" from treatment, requiring dose adjustment 2, 3
- Adrenal function should be monitored to prevent adrenal insufficiency, especially with doses above 400 mg daily 5
Special Considerations
- Ketoconazole requires gastric acid for absorption; proton pump inhibitors should be avoided 2
- Drug interactions must be carefully evaluated before initiating treatment 2, 5
- Risk of QT prolongation exists, especially with concomitant use of certain medications 5
- In severe cases where ketoconazole alone is insufficient, combination therapy with other agents like octreotide may be considered 6
Duration of Treatment
- For hypercortisolism, ketoconazole is primarily used as a bridge therapy while awaiting definitive treatment (surgery or radiotherapy) 1, 7
- Long-term use has been documented in some cases for up to 13 years when other treatments have failed 3, 8
- In children and adolescents, ketoconazole has a limited role in long-term treatment due to adverse effects 1
Adverse Effects
- Hepatotoxicity occurs in 10-20% of patients, typically within the first 6 months of treatment 2, 5
- Gastrointestinal disturbances are common (5-20% of patients) 2
- Men may experience hypogonadism and gynecomastia with prolonged treatment 2, 4
- Adrenal insufficiency may occur, particularly with higher doses 5, 4
- Skin rash is observed in approximately 5% of patients 2
Clinical Efficacy
- Ketoconazole normalizes UFC in approximately 64-85% of patients with Cushing's syndrome 2, 3
- Clinical improvement typically follows biochemical control, including decreased body weight, improved blood pressure, better glucose metabolism, and decreased muscle weakness 2
- Some patients may achieve normalization with lower doses (200-400 mg daily) 9, 8
Ketoconazole remains a valuable option for controlling hypercortisolism, particularly as a bridge to definitive therapy. However, careful monitoring is essential due to potential serious adverse effects, especially hepatotoxicity 2, 5.